Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunjong Ji

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Stem Cells and Development|September 10, 2016
Propagating Humanized BLT Mice for the Study of Human Immunology and ImmunotherapyDrake J Smith, Levina J Lin, Heesung Moon, et al.
The Oncologist|February 27, 2023
Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020Nirosha D Perera, Tiffany R Bellomo, Walker M Schmidt, et al.
Acta Neuropathologica|October 18, 2023
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterationsHolly J Roberts, Sunjong Ji, Alberto Picca, et al.
Neuro-Oncology|February 9, 2022
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline gliomaEvan Cantor, Kyle Wierzbicki, Rohinton S Tarapore, et al.
Research Square|July 3, 2026
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade GliomaCarl Koschmann, Kallen Schwark, Kelsey Wink, et al.
Cancer Cell|May 16, 2025
Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosisDerek Dang, Akash Deogharkar, John McKolay, et al.
Cancer Cell|December 1, 2023
A road map for the treatment of pediatric diffuse midline gliomaCarl Koschmann, Wajd N Al-Holou, Marta M Alonso, et al.
Cancer Discovery|August 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic PathwaysSriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Cancer Discovery|March 3, 2025
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic PathwaysSriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
G3 (Bethesda, Md.)|February 9, 2021
A functional genomics screen identifying blood cell development genes in Drosophila by undergraduates participating in a course-based research experienceCory J Evans, John M Olson, Bama Charan Mondal, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Stem Cells and Development|September 10, 2016
Propagating Humanized BLT Mice for the Study of Human Immunology and ImmunotherapyDrake J Smith, Levina J Lin, Heesung Moon, et al.
The Oncologist|February 27, 2023
Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020Nirosha D Perera, Tiffany R Bellomo, Walker M Schmidt, et al.
Acta Neuropathologica|October 18, 2023
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterationsHolly J Roberts, Sunjong Ji, Alberto Picca, et al.
Neuro-Oncology|February 9, 2022
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline gliomaEvan Cantor, Kyle Wierzbicki, Rohinton S Tarapore, et al.
Research Square|July 3, 2026
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade GliomaCarl Koschmann, Kallen Schwark, Kelsey Wink, et al.
Cancer Cell|May 16, 2025
Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosisDerek Dang, Akash Deogharkar, John McKolay, et al.
Cancer Cell|December 1, 2023
A road map for the treatment of pediatric diffuse midline gliomaCarl Koschmann, Wajd N Al-Holou, Marta M Alonso, et al.
Cancer Discovery|August 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic PathwaysSriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Cancer Discovery|March 3, 2025
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic PathwaysSriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
G3 (Bethesda, Md.)|February 9, 2021
A functional genomics screen identifying blood cell development genes in Drosophila by undergraduates participating in a course-based research experienceCory J Evans, John M Olson, Bama Charan Mondal, et al.
Pageof 2